Ascensia Diabetes Care’s Participation
Ascensia Diabetes Care, a global leader in diabetes care, joins MedTech Europe’s ‘Connecting the Dots’ film series, presenting the compelling story of Troy Ita, a patient advocate, and user of Eversense®.
This film series, curated by MedTech Europe and produced by BBC StoryWorks Commercial Productions, BBC Studios’ branded content studio, showcases the pivotal role of medical technologies in reshaping and enhancing healthcare landscapes.
Tip: Please fill out the form if you or a friend would like more information on CGM devices.
Unveiling the Role of Medical Technologies
The ‘Connecting the Dots’ series is a collection of impactful short films selected by MedTech Europe. These films explore breakthroughs in medical technology that are driving the future of healthcare and guiding the journey toward a healthier global population.
Among the twenty featured films, Ascensia’s mini-documentary-style video spotlights Troy’s experience with diabetes and underscores how advancements in continuous glucose monitoring (CGM) technology, particularly Eversense, have significantly improved his quality of life.
Read Guide about Wegovy Dosage Guide: The Best Way For Weight Loss
Troy’s Journey with Eversense CGM
Troy’s narrative in the film captures the evolution of his diabetes management journey and the profound impact of Eversense, the pioneering long-term CGM system.
Dr. Rakesh Patel, Troy’s endocrinologist, sheds light on the transformation witnessed in Troy’s diabetes care. “When Troy first came in to be treated, we used a regular glucometer before progressing onto a short-term continuous glucose monitoring system,
” Dr. Patel told the audience in the film. “He had some grievances with the short-term sensors – mainly because they tend to fall off regularly and come with the burden of replacing the sensor every 10 to 14 days.”
Empowering Lives through Long-term CGM
Troy highlights the pivotal change brought about by the long-term continuous glucose monitor. Due to the fact that I am required to drive for my profession on a regular basis, managing my diabetes has become quite difficult for me.
“The long-term continuous glucose monitor was a game-changer for me,” he said in the movie. “I can now monitor my glucose levels for an extended period of time.”
Elaine Anderson, VP of Global CGM and Commercial Operations at Ascensia Diabetes Care, expressed pride in bringing the benefits of long-term CGM systems to individuals with diabetes.
Must Read CGMs in noncritical care hospitals optimizes glycemic control
“We are humbled by the impact it can have on people’s lives,”
said the representative.
“MedTech Europe has provided an invaluable platform to showcase the transformative potential of medical technology through this film series.”
Eversense E3 CGM System: An Innovation in Diabetes Care
Designed by Senseonics and made accessible to patients by Ascensia, the Eversense E3 CGM System boasts the longest sensor wear duration of up to 6 months, offering a breakthrough in continuous glucose monitoring technology.
Also, read about Lighting the Global Diabetes Digital Therapeutics Market
Ascensia Diabetes Care, recognized for the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and as the exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, operates under the umbrella of PHC Holdings Corporation (TSE: 6523).
This participation in MedTech Europe’s film series reflects the commitment to advancing diabetes care through innovation and patient-centric solutions.
